Trial intelligence / Profile preview

Metformin for Tumor Oxygenation in Cervical Cancer

NCT02394652Phase 2Completed

Sponsor
University Health Network
Start
May 2015
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of liquid metformin (Aspargo Labs) in cervical neoplasm, sponsored by University Health Network. Started May 2015; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

cervical neoplasm

Beyond the preview

Go deeper on NCT02394652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02394652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call